Cargando…
What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review
BACKGROUND: Granulomatous disease is reported in at least 8–20% of patients with common variable immunodeficiency (CVID). Granulomatous disease mainly affects the lungs, and is associated with significantly higher morbidity and mortality. In half of patients with granulomatous disease, extrapulmonar...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773704/ https://www.ncbi.nlm.nih.gov/pubmed/33391274 http://dx.doi.org/10.3389/fimmu.2020.606389 |